Degree in Artificial intelligence- AI
Aartificial intelligence, Deep Learning, Large Language Models - LLMs, Leadership Skill, Machine learning techniques, Planning and organization, Python Programming, PyTorch, R Programming, TensorFlow
The candidate would lead and grow a team within a larger AI and computational organization that addresses key technical challenges in harnessing the viral proteome using in silico algorithms, including predicting binding activity between proteins, leading the generation, solution, and evaluation of CryoEM structures, assess differentiation of proteins based on surface properties, employ physics-based approaches to refine and optimize lead candidates, and institute predictive models to assess the developability of prospective viral proteins. An ideal candidate for this role would work constructively with partners from other organizations to shape, plan, and execute analyses for existing efforts while identifying innovative opportunities for altogether new approaches that create new insights and efficiencies at all stages of discovery, pre-clinical testing, and development.
As an organizational thought leader, the candidate should also be committed to and capable of expressing complex technical material and concepts to different audiences with a focus on prioritizing strategically relevant concepts and effectively weighing their relative benefits for decision-making. Moreover, the candidate should proactively use their technical and organizational skills to identify, organize, and initiate new internal and external activities that enable cross-functional dialogue and insight.
Finally, the ideal candidate thrives in a small-company, fast-paced, and intellectually challenging environment. The position will provide a unique opportunity to play a critical role in the advancement of Prologue’s computational discovery and preclinical platforms, through the development of disruptive approaches for biotherapeutic drug discovery.
Key Responsibilities:
Minimum Qualifications:
Preferred Qualifications:
About Flagship
Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
Flagship Pioneering is committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
At Flagship, we recognize there is no perfect candidate. If you have some of the experience listed above but not all, please apply anyway. Experience comes in many forms, skills are transferable, and passion goes a long way. We are dedicated to building diverse and inclusive teams and look forward to learning more about your unique background.
Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health and sustainability companies. Portfolio companies include Moderna, Indigo Agriculture, Inari Agriculture and Novomer.